(UroToday.com) Dr. Peter Albers presented the first results of the PROBASE, Prospective Randomized Evaluation of Risk-adapted Prostate-specific Antigen Screening in Young Men: The PROBASE Trial, a randomized controlled trial of risk-adapted prostate cancer screening beginning in men at age 45 vs 50 years old.